What Is Semaglutide? A Complete Guide to GLP-1 Weight Loss

What Is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist — a class of medications that mimic a naturally occurring hormone in your gut. Originally developed by Novo Nordisk to treat type 2 diabetes (sold as Ozempic®), semaglutide was later FDA-approved in 2021 at a higher dose specifically for chronic weight management under the brand name Wegovy®.

Since then, it has become one of the most studied and prescribed weight-loss medications in history — and for good reason. Clinical trials show it helps people lose significantly more weight than diet and exercise alone.

How Does Semaglutide Work?

Semaglutide works through multiple mechanisms that target the root causes of overeating and weight gain:

1. Appetite Suppression

GLP-1 receptors are found throughout the brain, including the hypothalamus — the region that regulates hunger and satiety. Semaglutide activates these receptors, reducing appetite and increasing feelings of fullness. Most people on semaglutide notice they feel satisfied with much smaller portions.

2. Slowed Gastric Emptying

Semaglutide slows the rate at which food leaves your stomach, which prolongs the sensation of fullness after eating and blunts post-meal blood sugar spikes.

3. Reduced Food Cravings

Emerging research suggests semaglutide may reduce "food noise" — the constant mental preoccupation with eating. Many patients report that cravings for high-calorie foods diminish substantially.

What Do the Clinical Trials Show?

The landmark STEP (Semaglutide Treatment Effect in People with obesity) trials, published in the New England Journal of Medicine, produced remarkable results:

• STEP 1: Adults with obesity (no diabetes) lost an average of 14.9% of body weight over 68 weeks on 2.4 mg semaglutide versus 2.4% with placebo.
• STEP 3: When combined with intensive behavioral counseling, average weight loss reached 16%.
• STEP 5: Weight loss was maintained at 2 years, with participants keeping off an average of 15.2% of their starting weight.

To put that in perspective: a 200-pound person could expect to lose 28-32 pounds on average. Some patients lose considerably more.

Who Is Semaglutide For?

FDA-approved criteria for semaglutide for weight loss include adults with:

• A BMI of 30 or higher (obesity), OR
• A BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.

It is not appropriate for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), or those who are pregnant.

Dosing and Administration

Semaglutide for weight loss is injected subcutaneously (under the skin) once per week. The dose is gradually increased over 16-20 weeks to minimize side effects:

• Weeks 1-4: 0.25 mg/week
• Weeks 5-8: 0.5 mg/week
• Weeks 9-12: 1.0 mg/week
• Weeks 13-16: 1.7 mg/week
• Week 17+: 2.4 mg/week (maintenance)

Compounded Semaglutide

Due to high demand and supply constraints, compounded semaglutide has become widely available through licensed telehealth providers. Compounded versions contain the same active ingredient and are significantly more affordable than brand-name Wegovy. Learn more about semaglutide options at AvataCore →

How Long Do You Stay on Semaglutide?

Semaglutide is designed for long-term use. Like blood pressure or cholesterol medication, it works best when taken consistently. Studies show that stopping semaglutide typically results in regaining roughly two-thirds of the lost weight within a year, which is why most patients remain on it indefinitely or transition to a maintenance strategy with their provider.